𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of famotidine in the treatment of Parkinson's disease: a pilot study

✍ Scribed by S. P. Molinari; R. Kaminski; A. Di Rocco; M. D. Yahr

Publisher
Springer
Year
1995
Tongue
English
Weight
303 KB
Volume
9
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of acupuncture in the treatme
Evaluation of acupuncture in the treatment of Parkinson's disease: A double-blind pilot study
✍ Adrian Cristian; Meredith Katz; Eileen Cutrone; Ruth H. Walker πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 60 KB πŸ‘ 1 views

## Abstract As many as 40% of patients with Parkinson's disease (PD) use some form of complementary medicine during the course of their illness, and many try acupuncture. One nonblinded study of the effects of acupuncture in PD suggested that it might be helpful for some aspects of PD. We performed

Atomoxetine for the treatment of executi
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
✍ Laura Marsh; Kevin Biglan; Melissa Gerstenhaber; James R. Williams πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 1 views

## Abstract Executive dysfunction (ED) is a prominent and often disabling feature of cognitive impairment in Parkinson's disease (PD). Few studies have examined treatments. Given the role of noradrenergic pathology in ED, atomoxetine, a norepinephrine reuptake inhibitor indicated for attention defi

Excess burden of constipation in Parkins
Excess burden of constipation in Parkinson's disease: A pilot study
✍ Julie Kaye; Heather Gage; Alan Kimber; Lesley Storey; Patrick Trend πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 1 views

An analysis was undertaken of clinic-based questionnaires that asked people with Parkinson's disease and a control group of older people without a known neurological condition about their experiences of constipation. People with Parkinson's disease report higher constipation on a validated objective

A pilot study of risk factors for dement
A pilot study of risk factors for dementia in Parkinson's disease
✍ Dr. Karen Marder; Pamela Flood; Lucien Cote; Richard Mayeux πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 514 KB

## Abstract To determine whether the risk factors for dementia in idiopathic Parkinson's disease (IPD) are similar to the risk factors for Alzheimer's disease, we conducted a case‐control study of potential risk factors. A structured interview as was administered to surrogates of 17 demented subjec

Open-label pilot study of levetiracetam
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
✍ Theresa A. Zesiewicz; Kelly L. Sullivan; John L. Maldonado; William O. Tatum; Ro πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

## Abstract We evaluated the tolerability and preliminary efficacy of levetiracetam (LEV; Keppra) in reducing levodopa‐induced dyskinesias in Parkinson's disease (PD) in an open‐label pilot study. Nine PD patients who were experiencing peak‐dose dyskinesias for at least 25% of the awake day and wer